Inactive Instrument

PPD, Inc.

Equities

PPD

US69355F1021

Biotechnology & Medical Research

PPD, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2021

February 23, 2021 at 04:05 pm EST

PPD, Inc. provided earnings guidance for the first quarter and full year of 2021. For the quarter, the company expects revenue to be in the range of $1,277 million to $1,302 million. For the full year, the company expects revenue to be in the range of $5,145 million to $5,304 million.

Latest news about PPD, Inc.

PPD, Inc. acquired Vigi Medsafe Private Limited from the shareholders of Vigi Medsafe .	22-04-19	CI
Chilean court rejects appeal to stop tender for new lithium contracts	22-01-07	RE
PPD, Inc.(NasdaqGS:PPD) dropped from S&P TMI Index	21-12-13	CI
PPD, Inc.(NasdaqGS:PPD) dropped from S&P Global BMI Index	21-12-13	CI
PPD, Inc.(NasdaqGS:PPD) dropped from NASDAQ Composite Index	21-12-08	CI
Thermo Fisher Scientific Inc. completed the acquisition of PPD, Inc. from Hellman & Friedman Capital Partners VII, L.P. managed by Hellman & Friedman LLC, Carlyle Partners VI, L.P. managed by The Carlyle Group Inc. (NasdaqGS:CG) and others.	21-12-07	CI
UK Regulator Clears Thermo Fisher's Acquisition of PPD	21-12-03	MT
British Competition Watchdog Clears Thermo Fisher's $21 Billion PPD Purchase	21-12-03	MT
FTSE 100 to Open Higher	21-12-03	DJ
UK Regulator Won't Refer Thermo Fisher's Acquisition of PPD for Further Review	21-12-03	DJ
EU to Decide on Thermo Fisher's $21 Billion PPD Purchase by Dec. 7	21-11-03	MT
EU antitrust decision on Thermo Fisher's PPD deal due by Dec. 7	21-11-03	RE
Transcript : PPD, Inc., Q3 2021 Earnings Call, Oct 28, 2021	21-10-28
Earnings Flash (PPD) PPD Posts Q3 Revenue $1.56B	21-10-27	MT
Earnings Flash (PPD) PPD Reports Q3 EPS $0.43	21-10-27	MT
PPD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-27	CI
Thermo Fisher Scientific : Prices $5.85 Billion Offering of Senior Notes	21-10-20	MT
Thermo Fisher Scientific : Files Shelf Registration for Dollar-Denominated Senior Notes Offering	21-10-19	MT
Thermo Fisher Scientific : UK Competition Regulator to Launch Inquiry Into Thermo Fisher's Proposed Acquisition of PPD	21-10-15	MT
UK Competitions Regulator Initiates Merger Inquiry Into Thermo Fisher's Purchase of PPD	21-10-15	MT
UK Watchdog to Investigate Thermo Fisher's Planned Acquisition of PPD	21-10-15	DJ
Thermo Fisher Scientific : Prices Notes Offering Totaling 5.25 Billion Euros	21-10-07	MT
Science 37 Holdings, Inc. announced that it has received $200 million in funding from a group of investors	21-10-05	CI
Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs	21-09-30	CI
Field Trip Health : To Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104 Compound	21-09-09	MT

Chart PPD, Inc.

Duration

Period

More charts

Company Profile

PPD Inc is a United States-based company. The Company is engaged in providing clinical development and laboratory services to pharmaceutical, and biotechnology industries. It provides solutions such as early development, product development and consulting, site and patient centric solutions. It also provides laboratories such as bioanalytical lab, biomarker lab, central lab, and vaccine science lab.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+29.77%	49.46B
IQVIA HOLDINGS INC.	+1.00%	42.58B
LONZA GROUP AG	+50.24%	42.49B
CELLTRION, INC.	-5.26%	29.09B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.61B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.64B
BIO-TECHNE CORPORATION	+8.22%	13.16B
MEDPACE HOLDINGS, INC.	+32.41%	12.55B
UNITED THERAPEUTICS CORPORATION	+24.01%	12.1B

Other Biotechnology & Medical Research